Range
26.19 - 27.75
Vol / Avg.
206.3K/280K
Div / Yield
-
52 Wk
19.12 - 37.46
Mkt Cap
1B
Payout Ratio
-
Open
26.94
P/E
-
EPS
-0.64
Shares
37.6M
Outstanding
37.6M
Total Float
32.3M
Benzinga - 16 hours ago
Benzinga - May 12, 2021, 4:36PM
Benzinga - Apr 26, 2021, 1:27PM
Benzinga - Mar 15, 2021, 4:07PM
Benzinga - Jan 8, 2021, 8:37AM
Benzinga - Nov 10, 2020, 4:47PM
Benzinga - Sep 8, 2020, 8:32AM
load more
Sector: Health Care.Industry: Biotechnology
Avidity Biosciences Inc is a bio-technology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.560-0.640 -0.0800
REV1.000M2.704M1.704M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RNAAvidity Biosciences2.72%1B

Avidity Biosciences Frequently Asked Questions

Q

How do I buy Avidity Biosciences (RNA) stock?

A

You can purchase shares of Avidity Biosciences (NASDAQ: RNA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Avidity Biosciences's (RNA) competitors?

A

Other companies in Avidity Biosciences’s space includes: Immunovant (NASDAQ:IMVT), Syndax Pharmaceuticals (NASDAQ:SNDX), ChemoCentryx (NASDAQ:CCXI), Mesoblast (NASDAQ:MESO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).

Q

What is the target price for Avidity Biosciences (RNA) stock?

A

The latest price target for Avidity Biosciences (NASDAQ: RNA) was reported by Needham on June 17, 2021. The analyst firm set a price target for 50.00 expecting RNA to rise to within 12 months (a possible 86.57% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Avidity Biosciences (RNA)?

A

The stock price for Avidity Biosciences (NASDAQ: RNA) is $26.8 last updated Thu Jun 17 2021 20:00:00 GMT+0000 (Coordinated Universal Time).

Q

Does Avidity Biosciences (RNA) pay a dividend?

A

There are no upcoming dividends for Avidity Biosciences.

Q

When is Avidity Biosciences (NASDAQ:RNA) reporting earnings?

A
Avidity Biosciences’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Avidity Biosciences (RNA) going to split?

A

There is no upcoming split for Avidity Biosciences.

Q

What sector and industry does Avidity Biosciences (RNA) operate in?

A

Avidity Biosciences is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.